Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-253 Cr₹319 Cr₹30 Cr₹-175 Cr₹-95 Cr

What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS is ₹-253 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-253 Cr
Mar2024₹319 Cr
Mar2023₹30 Cr
Mar2022₹-175 Cr
Mar2021₹-95 Cr

How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-253 Cr
Negative
Mar2024 ₹319 Cr
955.47
Mar2023 ₹30 Cr
Positive
Mar2022 ₹-175 Cr
Negative
Mar2021 ₹-95 Cr -

Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹134,991.1 Cr -7.2% -8% 27.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics
MANKIND PHARMA ₹82,460.4 Cr -1.1% -11.1% -16.9% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-7.2%

-8%

27.6%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses